FUSAFUNGINE: 13 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
13
Total FAERS Reports
0
Deaths Reported
10
Hospitalizations
13
As Primary/Secondary Suspect
7
Life-Threatening
1
Disabilities
First Report: 19931208 · Latest Report: 20151110
What Are the Most Common FUSAFUNGINE Side Effects?
#1 Most Reported
Muscle twitching
7 reports (53.8%)
#2 Most Reported
Muscle spasms
7 reports (53.8%)
#3 Most Reported
Memory impairment
7 reports (53.8%)
All FUSAFUNGINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cognitive disorder | 7 | 53.9% | 0 | 7 |
| Decreased appetite | 7 | 53.9% | 0 | 7 |
| Fatigue | 7 | 53.9% | 0 | 7 |
| Memory impairment | 7 | 53.9% | 0 | 7 |
| Muscle spasms | 7 | 53.9% | 0 | 7 |
| Muscle twitching | 7 | 53.9% | 0 | 7 |
| Conjunctivitis | 6 | 46.2% | 0 | 6 |
| Disturbance in attention | 6 | 46.2% | 0 | 6 |
| Disturbance in social behaviour | 6 | 46.2% | 0 | 6 |
| Dyspnoea | 6 | 46.2% | 0 | 6 |
| Nervousness | 6 | 46.2% | 0 | 6 |
| Post 5-alpha-reductase inhibitor syndrome | 6 | 46.2% | 0 | 6 |
| Abdominal pain | 5 | 38.5% | 0 | 5 |
| Abnormal loss of weight | 5 | 38.5% | 0 | 5 |
| Aggression | 5 | 38.5% | 0 | 5 |
| Alpha 2 globulin decreased | 5 | 38.5% | 0 | 5 |
| Androgen insensitivity syndrome | 5 | 38.5% | 0 | 5 |
| Anger | 5 | 38.5% | 0 | 5 |
| Anhedonia | 5 | 38.5% | 0 | 5 |
| Aphasia | 5 | 38.5% | 0 | 5 |
Who Reports FUSAFUNGINE Side Effects? Age & Gender Data
Gender: 30.8% female, 69.2% male. Average age: 32.9 years. Most reports from: DE. View detailed demographics →
Is FUSAFUNGINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 0 |
| 2006 | 5 | 0 | 5 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 0 |
What Is FUSAFUNGINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 7 |
Official FDA Label for FUSAFUNGINE
Official prescribing information from the FDA-approved drug label.